20% ORIGINAL ISSUE DISCOUNT UNSECURED CONVERTIBLE DEBENTURE DUE ON OR BEFORE NOVEMBER 30, 2017Protea Biosciences Group, Inc. • August 29th, 2017 • Pharmaceutical preparations • New York
THIS 20% ORIGINAL ISSUE DISCOUNT UNSECURED CONVERTIBLE DEBENTURE, dated as of June 5, 2017 between the “Holder” (defined below) and PROTEA BIOSCIENCES GROUP, INC., a Delaware corporation (the “Company”), having its principal place of business at 1311 Pineview Drive, Suite 501, Morgantown, WV 26505 (the “Exchange Agreement”).
SUBSCRIPTION AGREEMENTSubscription Agreement • August 29th, 2017 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • New York
SUBSCRIPTION AGREEMENT (this “Agreement”) made as of the last date set forth on the signature page hereof between Protea Biosciences Group, Inc. (the “Company”), and the undersigned (the “Lender”).
